Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	Quarterly REPORT pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2023

Or

☐	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____________ to _____________

Commission File No. 001-40071

AUDDIA INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		45-4257218
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2100 Central Ave., Suite 200 Boulder, Colorado		80301
Address of Principal Executive Offices		Zip Code

(303) 219-9771

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Common Stock, par value $0.001 per share	AUUD	The Nasdaq Stock Market

Warrants, each exercisable for one share of Common Stock	AUUDW	The Nasdaq Stock Market

Indicate by check mark whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐	Accelerated Filer ☐
Non-accelerated Filer ☒	Smaller Reporting Company ☒
	Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act). Yes ☐ No ☒

As of November 13, 2023, there were 19,947,223 shares of the registrant’s common stock, $0.001 par value per share, outstanding.

AUDDIA INC.

2023 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page No.
PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements	4
	Condensed Balance Sheets	4
	Condensed Statements of Operations	5
	Condensed Statements of Changes in Shareholders’ Equity	6
	Condensed Statements of Cash Flows	7
	Notes to Condensed Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	29
Item 4.	Controls and Procedures	29

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 3.	Defaults Upon Senior Securities	31
Item 4.	Mine Safety Disclosures	31
Item 5.	Other Information	31
Item 6.	Exhibits	31
	Signatures	33

Unless we state otherwise or the context otherwise requires, the terms “Auddia,” “we,” “us,” “our” and the “Company” refer to Auddia Inc., a Delaware corporation.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, or Quarterly Report, contains forward-looking statements that involve risks and uncertainties. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expects”, “intends”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, “continue” or the negative of these terms or other comparable terminology.

Forward-looking statements are neither historical facts nor assurances of future performance, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

	·	the ultimate impact of the ongoing coronavirus (COVID-19) pandemic, or any other health epidemic, on our business, results of operations, cash flows, financial condition and liquidity, and the global economy as a whole;
	·	the sufficiency of our existing cash to meet our working capital and capital expenditure needs over the next 12 months and our need to raise additional capital;
	·	our ability to generate revenue from new software services;
	·	our limited operating history;
	·	our ability to maintain proper and effective internal financial controls;
	·	our ability to continue to operate as a going concern;
	·	changes in laws, government regulations and policies and interpretations thereof;
	·	our ability to obtain and maintain protection for our intellectual property;
	·	the risk of errors, failures or bugs in our platform or products;
	·	our ability to attract and retain qualified employees and key personnel;
	·	our ability to manage our rapid growth and organizational change effectively;
	·	the possibility of security vulnerabilities, cyberattacks and network disruptions, including breaches of data security and privacy leaks, data loss, and business interruptions;
	·	our compliance with data privacy laws and regulations;
	·	our ability to develop and maintain our brand cost-effectively; and
	·	the other factors set forth elsewhere in this Quarterly Report and in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022.

These forward-looking statements speak only as of the date of this Form 10-Q and are subject to business and economic risks. We do not undertake any obligation to update or revise the forward-looking statements to reflect events that occur or circumstances that exist after the date on which such statements were made, except to the extent required by law.

PART I – FINANCIAL INFORMATION

Item 1.

Financial Statements

Auddia Inc.

Condensed Balance Sheets


	September 30, 2023			December 31, 2022
ASSETS		(Unaudited)			(Audited)
Current assets:
Cash	$	2,199,678		$	1,661,434
Accounts receivable, net		574			137
Prepaid insurance		56,704			—
Total current assets		2,256,956			1,661,571

Non-current assets:
Property and equipment, net of accumulated depreciation		22,084			41,080
Software development costs, net of accumulated amortization		3,545,610			4,134,225
Deferred offering costs		170,259			222,896
Prepaids and other non-current assets		47,364			51,754
Total non-current assets		3,785,317			4,449,955
Total assets	$	6,042,273		$	6,111,526

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	587,641		$	324,138
Notes payable to related party, net of debt issuance costs		2,993,639			1,775,956
Stock awards liability		45,981			161,349
Total current liabilities		3,627,261			2,261,443
Total liabilities		3,627,261			2,261,443

Commitments and contingencies (Note 5)		–			–

Shareholders' equity:
Preferred stock - $0.001 par value, 10,000,000 authorized and 0 shares issued and outstanding		–			–
Common stock - $0.001 par value, 100,000,000 authorized and 19,947,223 and 12,654,949 shares issued and outstanding September 30, 2023 and December 31, 2022		19,947			12,654
Additional paid-in capital		80,725,555			75,573,263
Accumulated deficit		(78,330,490	)		(71,735,834	)
Total shareholders' equity		2,415,012			3,850,083
Total liabilities and shareholders' equity	$	6,042,273		$	6,111,526

The accompanying notes are an integral part of these unaudited condensed financial statements.

Auddia Inc.

Condensed Statements of Operations (Unaudited)


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2023			2022			2023			2022
Revenue	$	–		$	–		$	–		$	–

Operating expenses:
Direct cost of services		43,470			32,712			130,809			128,806
Sales and marketing		316,297			298,924			765,176			1,396,010
Research and development		227,133			181,596			617,622			481,611
General and administrative		777,496			540,220			2,596,831			2,400,503
Depreciation and amortization		465,166			274,839			1,350,820			721,971
Total operating expenses		1,829,562			1,328,291			5,461,258			5,128,901
Loss from operations		(1,829,562	)		(1,328,291	)		(5,461,258	)		(5,128,901	)

Other (expense) income:
Interest expense		(286,920	)		(2,023	)		(1,133,398	)		(5,058	)
Total other expense		(286,920	)		(2,023	)		(1,133,398	)		(5,058	)
Loss before income taxes		(2,116,482	)		(1,330,314	)		(6,594,656	)		(5,133,959	)
Provision for income taxes		–			–			–			–
Net loss	$	(2,116,482	)	$	(1,330,314	)	$	(6,594,656	)	$	(5,133,959	)

Net loss per share attributable to common stockholders
Basic and diluted	$	(0.11	)	$	(0.11	)	$	(0.41	)	$	(0.41	)

Weighted average common shares outstanding
Basic and diluted		19,947,223			12,514,763			16,043,086			12,498,206

The accompanying notes are an integral part of these unaudited condensed financial statements.

Auddia Inc.

Condensed Statements of Changes in Shareholders’ Equity (Unaudited)


	For The Three and Nine Months Ended September 30, 2023
		Common Stock
		Number of Shares		Par Value		Additional Paid-In-Capital			Accumulated Deficit			Total
Balance, January 1, 2023		12,654,949	$	12,654	$	75,573,262		$	(71,735,834	)	$	3,850,083

Exercise of Restricted Stock Units		195,760		196		42,601			–			42,797
Share-based compensation		–		–		357,680			–			357,680
Net loss		–		–		–			(2,155,312	)		(2,155,312	)
Balance, March 31, 2023		12,850,709	$	12,850	$	75,973,543		$	(73,891,146	)	$	2,095,247

Issuance of common shares, net of costs		7,096,514		7,097		3,956,787			–			3,963,884
Exercise of Restricted Stock Units		–		–		(42,797	)		–			(42,797	)
Issuance of warrants		–		–		383,004			–			383,004
Share-based compensation		–		–		224,856			–			224,856
Revaluation of share-based compensation liability		–		–		30,445			–			30,445
Net loss		–		–		–			(2,322,862	)		(2,322,862	)
Balance, June 30, 2023		19,947,223	$	19,947	$	80,525,838		$	(76,214,008	)	$	4,331,777

Share-based compensation		–		–		217,141			–			217,141
Revaluation of share-based compensation liability		–		–		(17,424	)		–			(17,424	)
Net loss		–		–		–			(2,116,482	)		(2,116,482	)
Balance, September 30, 2023	$	19,947,223	$	19,947	$	80,725,555		$	(78,330,490	)	$	2,415,012


		For The Three and Nine Months Ended September 30, 2022
		Common Stock
		Number of Shares		Par Value		Additional Paid-In-Capital			Accumulated Deficit			Total
Balance, January 1, 2022		12,416,408	$	12,416	$	74,236,910		$	(64,838,389	)	$	9,410,937

Exercise of Restricted Stock Units		98,355		98		(98	)		–			–
Share-based compensation		–		–		385,908			–			385,908
Reclassification of share-based compensation liability		–		–		(128,534	)		–			(128,534	)
Net loss		–		–		–			(1,753,258	)		(1,753,258	)
Balance, March 31, 2022		12,514,763	$	12,514	$	74,494,186		$	(66,591,647	)	$	7,915,053

Share-based compensation		–		–		285,921			–			285,921
Reclassification of share-based compensation liability		–		–		(7,262	)		–			(7,262	)
Net loss		–		–		–			(2,050,385	)		(2,050,385	)
Balance, June 30, 2022		12,514,763	$	12,514	$	74,772,845		$	(68,642,032	)	$	6,143,327

Share-based compensation		–		–		26,657			–			26,657
Revaluation of share-based compensation liability		–		–		(72,315	)		–			(72,315	)
Net loss		–		–		–			(1,330,314	)		(1,330,314	)
Balance, September 30, 2022	$	12,514,763	$	12,514	$	74,727,187		$	(69,972,348	)	$	4,767,353

The accompanying notes are an integral part of these unaudited condensed financial statements.

Auddia Inc.

Condensed Statements of Cash Flows (Unaudited)


	Nine Months Ended September 30,
	2023			2022
Cash flows from operating activities:
Net loss	$	(6,594,656	)	$	(5,133,959	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Finance charge associated with debt issuance cost		850,688			–
Depreciation and amortization		1,350,820			721,971
Share-based compensation expense		799,677			698,486
Change in assets and liabilities:
Accounts receivable		(437	)		52
Prepaid insurance		(56,705	)		–
Prepaids and other non-current assets		4,390			(1,065	)
Accounts payable and accrued liabilities		241,269			92,403
Net cash used in operating activities		(3,404,954	)		(3,622,112	)

Cash flows from investing activities:
Software capitalization		(743,208	)		(1,673,517	)
Purchase of property and equipment		–			(3,809	)
Net cash used in investing activities		(743,208	)		(1,677,326	)

Cash flows from financing activities:
Net settlement of share-based compensation liability		(80,115	)		(88,723	)
Proceeds from related party debt		750,000			–
Proceeds from issuance of common shares		4,016,521			–
Net cash provided by (used in) financing activities		4,686,406			(88,723	)

Net increase in cash		538,244			(5,388,161	)

Cash, beginning of year		1,661,434			6,345,291

Cash and restricted cash, end of period	$	2,199,678		$	957,130

Supplemental disclosures of cash flow information:
Cash paid for Interest	$	6,000		$	5,058

Supplemental disclosures of non-cash activity:
Reclassification of deferred offering cost	$	52,637		$	–
Original issue discount and issuance of warrants on related party debt	$	458,004		$	–

The accompanying notes are an integral part of these unaudited condensed financial statements.

Auddia Inc.

Notes to Condensed Financial Statements (Unaudited)

Note 1 - Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

Description of Business

Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.

Basis of Presentation

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

Interim Financial Information

The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2022 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The condensed financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company's common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.

Risks and Uncertainties

The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.

Emerging Growth Company Status

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.

Going Concern

The Company had cash of $2,199,678 as of September 30, 2023. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company will be forced to delay, reduce, or eliminate technology development and commercialization efforts.

As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 8) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand by February 2024.

Cash

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents as of September 30, 2023 or December 31, 2022.

The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2023, the Company had approximately $1.9 million in excess of federally insured limits. As of December 31, 2022, the Company had approximately $1.4 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.

Software Development Costs

The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable.

The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies.

Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. We determined that no such impairments were required during the three months and nine months ended September 30, 2023. Software development costs of $213,705 and $394,893 were capitalized for the three months ended September 30, 2023, and 2022, respectively and $743,208 and $1,673,517 were capitalized for the nine months ended September 30, 2023 and 2022, respectively. Amortization of capitalized software development costs were $458,973 and $262,703 for the three months ended September 30, 2023, and 2022, respectively and $1,331,823 and $693,441 for the nine months ended September 30, 2023 and 2022, respectively and are included in depreciation and amortization expense in the Company’s condensed statement of operations.

Revenue Recognition

Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority.

Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions.

Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.

Share-Based Compensation

The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718.

Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods.

Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.

Recently Adopted ASUs

ASU 2016-13-Financial Instruments-Credit Losses- The new guidance makes significant changes to the accounting for credit losses on financial instruments and disclosures about them. Specifically, the new CECL impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, that considers forecasts of future economic conditions in addition to information about past events and current conditions. The Company adopted the new standard beginning January 1, 2023. The adoption of the new standard did not have a material impact on the Company’s financial statements.

Note 2 – Property & Equipment and Software Development Costs

Property and equipment and software development costs consisted of the following as of:


	September 30, 2023			December 31, 2022

Computers and equipment	$	99,939		$	99,939
Furniture		7,263			7,262
Accumulated depreciation		(85,118	)		(66,121	)
Total property and equipment, net	$	22,084		$	41,080


Software development costs	$	7,369,257		$	6,626,049
Accumulated amortization		(3,823,647	)		(2,491,824	)
Total software development costs, net	$	3,545,610		$	4,134,225

The Company recognized depreciation expense of $6,193 and $12,136 for the three months ended September 30, 2023, and 2022, respectively related to property and equipment and amortization expense of $458,973 and $262,703 for the three months ended September 30, 2023, and 2022, respectively related to software development costs. The Company recognized depreciation expense of $18,997 and $28,529 for the nine months ended September 30, 2023, and 2022, respectively related to property and equipment and amortization expense of $1,331,823 and $693,441 for the nine months ended September 30, 2023, and 2022, respectively related to software development costs.

Note 3 – Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following:


	September 30, 2023		December 31, 2022

Accounts payable and accrued liabilities	$	269,159	$	289,955
Credit cards payable		14,517		6,072
Accrued interest		303,965		28,111
	$	587,641	$	324,138

Note 4 – Notes Payable to Related Party, net of debt issuance costs

In November 2022, the Company entered into a Secured Bridge Note (the “Prior Note”) financing with an existing shareholder of the Company. The principal amount of the Prior Note was $2,200,000 including an original issue discount of $200,000. The Prior Note bears interest at a stated rate of 10% and had an original maturity date of May of 2023. The Prior Note is secured by a lien on substantially all of the Company’s assets. At maturity, the lender had the option to convert any original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $1.23 per share. The conversion right is available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. In connection with the Prior Note financing, the Company issued 300,000 common stock warrants with a five-year term and an exercise price of $2.10 per share. The warrants were valued at $361,878, which was recorded as an additional debt discount. During May of 2023, the Company extended the maturity date by six months to November 2023 at an increased annual interest rate of 20% and the issuance of an additional 300,000 warrants. The additional warrants were valued at $94,083, which was also recorded as an additional debt discount. The embedded conversion option was not accounted for separately as, in accordance with the guidance outlined in ASC 815-40, it was considered indexed to the Company’s shares. Similarly, the issued warrants were classified in equity as they were also considered indexed to the Company’s shares in accordance with ASC 815-40.

In connection with an additional financing with the same related party during April of 2023, the Company cancelled the original 300,000 warrants issued with the Prior Note and issued 600,000 new common stock warrants with a five-year term and an exercise price of $0.61 per share. The Company recognized the modification in accordance with ASC 815-40-35, which resulted in the recognition of additional debt discount in the amount of $35,981. Upon issue of the new common stock warrants, 300,000 were fully vested and immediately exercisable upon issue. The remaining 300,000 warrants were unvested.

During May of 2023, the Company extended the maturity date of the Prior Notes by six months to November 2023 at an increased annual interest rate of 20%. In connection with this extension, the 300,000 outstanding unvested warrants became vested and exercisable.

As of September 30, 2023, and December 31, 2022, the balance of the Prior Note, net of debt issuance costs, was $2,168,639 and $1,775,956, respectively. Interest expense related to the Prior Note for the three and nine months ended September 30, 2023, was $157,298 and $762,112.

As noted above, the Company entered into an additional Secured Bridge Note (“New Note”) financing with the same accredited investor and significant existing shareholder during April of 2023. In addition, the Company also amended the terms of the Prior Note. The principal amount of the New Note is $825,000 including an original issue discount of $75,000. The New Note bears interest at an annual stated rate of 10% with an original maturity date of July 2023. The New Note is secured by a lien on substantially all of the Company’s assets. At maturity the lender has the option to convert any original issue discount and accrued but unpaid interest into shares of the Company’s common stock at a fixed conversion price of $0.61 per share. The conversion right is available to the lender at the earlier of (i) maturity, or (ii) payback of all the principal. In connection with the New Note financing, the Company issued 325,000 common stock warrants with a five-year term and an exercise price of $0.61 per share and an additional 325,000 common stock warrants with a five-year term and an exercise price of $0.61 per share that are exercisable in the event that the loan term is extended. The warrants were valued at $252,940, which was recorded as additional debt discount. Similar to the accounting for the Prior Note, the embedded conversion option was not accounted for separately as, in accordance with the guidance outlined in ASC 815-40, it was considered indexed to the Company’s shares. In addition, the issued warrants were classified in equity as they were also considered indexed to the Company’s shares in accordance with ASC 815-40.

As of September 30, 2023, the balance of the New Note issued in April 2023, net of debt issuance costs, was $825,000. Interest expense related to the New Note for the three and nine months ended September 30, 2023 was $401,441, respectively.

On July 31, 2023, the Company extended the maturity date of the New Note to November 30, 2023. In connection with such extension, 325,000 outstanding unvested warrants became vested and exercisable.

Note 5 – Commitments and Contingencies

Operating Lease

In April 2021, the Company entered into a lease agreement for office space in Boulder, Colorado comprising 8,639 square feet. The lease commenced on May 15, 2021, and terminated after 12 months. The Company subsequently extended the lease through November 2022. In November 2022, the Company amended the lease, reducing the square footage rented to 2,160 with a base rent of $4,018 per month. The amended lease terminates after 13 months. Rent expense, as part of general and administrative expenses as included in the Condensed Statement of Operations, was $12,053 and $39,935 for the three months ended September 30, 2023, and 2022, respectively and $49,491 and $83,117 for the nine months ended September 30, 2023, and 2022, respectively.

Litigation

In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alleged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable or estimable as of the date the financial statements were issued.

NASDAQ Deficiencies

On May 23, 2023, we received a letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, based upon the Company’s reported stockholder’s equity of $2,095,247 at the end of March 31, 2023, we are not in compliance with the requirement to maintain a minimum stockholder’s equity of $2,500,000 for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1) the “Stockholders’ Equity Requirement”). We were provided a compliance period of 45 calendar days from the date of the Notice, or until July 7, 2023, to submit a plan to regain compliance with the Stockholder’s Equity Requirement, pursuant to Nasdaq Listing Rule 5810(c)(2)(A).

On July 10, 2023, the Company received a letter from Nasdaq advising that the Company had been granted an extension to file a Form 10-Q for the quarter-ended June 30, 2023 evidencing compliance with Stockholder’s Equity Requirement. The stockholder’s equity balance as of June 30, 2023 was $4,331,777, which is $1,831,778 over the $2.5 million Stockholders’ Equity Requirement. On August 25, 2023, Nasdaq confirmed that the Company had regained compliance with the Stockholders’ Equity Requirement and that this matter is now closed.

Separately, on April 24, 2023 we received a letter from Nasdaq indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the “Bid Price Requirement”).

The letter indicated that the Company will be provided 180 calendar days (or until October 23, 2023) in which to regain compliance. If at any time during this 180 calendar day period the bid price of the Company’s common stock closes at or above $1.00 per share for a minimum of ten consecutive business days, Nasdaq will provide the Company with a written confirmation of compliance and the matter will be closed.

On October 24, 2023, the Company received a written notice from the Nasdaq staff indicating that the Company had not regained compliance with the Bid Price Requirement and was not eligible for an additional 180 calendar day compliance period. As a result, the staff determined to delist the Company’s Common Stock from Nasdaq, unless the Company timely requests an appeal of the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.

The Company has requested a hearing before the Panel to appeal the October notice and to address compliance with the Bid Price Requirement. While the appeal process is pending, the suspension of trading of the Company’s common stock, will be stayed and the Common Stock will continue to trade on Nasdaq until the hearing process concludes and the Panel issues a written decision. The hearing is expected to occur in mid-January 2024.

The Company intends to consider all options to regain and maintain compliance with all Nasdaq continued listing requirements.

The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

Note 6 - Share-based Issuances

Stock Options

The following table presents the activity for stock options outstanding:

Schedule of stock option activity
	Options			Weighted Average Exercise Price
Outstanding - December 31, 2022		1,663,173		$	2.45
Granted		200,200			0.94
Forfeited/canceled		(206,454	)		1.51
Exercised		–			–
Outstanding - September 30, 2023		1,656,919		$	2.38

The following table presents the composition of options outstanding and exercisable:

	Options Outstanding				Options Exercisable
Exercise Prices	Number		Price	Life*	Number		Price*
$2.70	22,264	$	2.70	0.75	22,264	$	2.70
$2.90	53,128	$	2.90	4.11	53,128	$	2.90
$4.26	171,197	$	4.26	5.73	171,197	$	4.26
$2.79	772,194	$	2.79	7.23	553,122	$	2.79
$1.79	198,750	$	1.79	7.87	68,437	$	1.79
$1.21	389,386	$	1.21	8.95	292,039	$	1.21
$0.40	50,000	$	0.40	9.69	–	$	0.40
Total - September 30, 2023	1,656,919	$	2.38		1,160,187	$	2.59

*	Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

During the nine months ended September 30, 2023, the Company granted 200,200 stock options. Under the terms of the option agreements, the options are subject to certain vesting requirements. The fair value of each award is determined using the Black-Scholes option-pricing model which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, and the risk-free interest rate over the expected life of the option. The expected volatility was determined considering comparable companies historical stock prices as a peer group for the fiscal year the grant occurred and prior fiscal years for a period equal to the expected life of the option. The risk-free interest rate was the rate available from the St. Louis Federal Reserve Bank with a term equal to the expected life of the option. The expected life of the option was estimated based on a mid-point method calculation.

Restricted Stock Units

The following table presents the activity for restricted stock units outstanding:


	Restricted Stock Units			Weighted Average Grant Date Fair Value
Outstanding - December 31, 2022		563,859		$	2.14
Granted		37,500			1.24
Forfeited/canceled		(118,350	)		1.83
Vested/issued		(195,759	)		1.83
Outstanding - September 30, 2023		287,250		$	2.37

During the nine months ended September 30, 2023, the Company granted 37,500 restricted stock units. Under terms of the restricted stock agreement, the restricted stock units are subject to a certain vesting schedule.

In 2023, certain restricted stock unit holders elected a net-share settlement for vested shares to satisfy income tax requirements. The Company applied modification accounting in accordance with ASC 718 and recorded the expected value of these share-based awards as a liability. The Company recognized a share-based compensation liability as of September 30, 2023, of $45,981 related to the fair value of vested shares over the service period.

The Company recognized share-based compensation expense related to stock options and restricted stock units of $799,677 and $698,486 for the nine months ended September 30, 2023, and 2022, respectively. The remaining unvested share-based compensation expense of $1,447,278 is expected to be recognized over the next 90 months.

Warrants

The following table presents the activity for warrants outstanding:

Schedule of warrant outstanding
	Warrants		Weighted Average Exercise Price
Outstanding - December 31, 2022		4,472,099	$	4.62
Granted		950,000		0.61
Forfeited/canceled		–		–
Exercised		–		–
Outstanding - September 30, 2023		5,422,099	$	3.84

5,422,099 of the outstanding warrants are currently exercisable and have a weighted average remaining contractual life of approximately 2.69 years as of September 30, 2023.

Note 7 – Net Loss Per Share

Basic net loss per share is computed by dividing net loss, which is allocated based upon the proportionate amount of weighted average shares outstanding, to each class of shareholder’s stock outstanding during the period. For the calculation of diluted net loss per share, net loss per share attributable to common shareholders for basic net loss per share is adjusted by the effect of dilutive securities, including awards under our equity compensation plans.

As of September 30, 2023, and 2022, 7,079,016 shares and 6,271,219 shares, respectively of potentially dilutive weighted average shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented.

Note 8 – Equity Financings

Equity Line Sales of Common Stock

On November 14, 2022, the Company entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility.

In April and June 2023, the Company closed on three sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 2,361,514 common shares and received aggregate proceeds of approximately $1.3 million.

Any proceeds that the Company receives under the White Lion Purchase Agreement are expected to be used for working capital and general corporate purposes.

The aggregate number of shares of common stock that the Company can sell to White Lion under the White Lion Purchase Agreement (including the Commitment Shares) may in no case exceed 2,501,700 shares of the common stock (which is equal to approximately 19.99% of the shares of the common stock outstanding immediately prior to the execution of the White Lion Purchase Agreement) (the “Exchange Cap”), unless shareholder approval is obtained to issue purchase shares above the Exchange Cap, in which case the Exchange Cap will no longer apply.

The Company recognized all offering costs related to the equity line of credit as deferred offering costs in accordance with the guidance in ASC 835-30-S45.

Sale of Common Shares (S-3 offering)

In June 2023, the Company sold 4,735,000 shares of common stock in a registered public offering with net proceeds of $2.7 million.

Note 9 – Subsequent Events

Replacement Equity Line with White Lion

On November 6, 2023, the Company entered into a new Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the new Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time until December 31, 2024, up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. In connection with the new Common Stock Purchase Agreement, the parties agreed to terminate the previous Common Stock Purchase Agreement with White Lion.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and related notes included elsewhere in this Quarterly Report and our audited financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on March 23, 2023. This discussion and analysis and other parts of this Quarterly Report contain forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under Part II, Item 1A, “Risk Factors” and elsewhere in this Quarterly Report. You should carefully read the “Risk Factors” section of this Quarterly Report and of our Annual Report on Form 10-K for the year ended December 31, 2022, to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitled “Special Note Regarding Forward-Looking Statements.”

Overview

Auddia is a technology company headquartered in Boulder, CO that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia is leveraging these technologies within its industry-first audio Superapp, faidr (previously known as the Auddia App).

faidr gives consumers the opportunity to listen to any AM/FM radio station with no commercials while personalizing the listening experience through skips and the insertion of on-demand content, including popular and new music, news, and weather. The faidr app represents the first-time consumers can combine the local content uniquely provided by AM/FM radio with commercial-free and personalized listening many consumers demand from digital-media consumption. In addition to commercial-free AM/FM, faidr includes podcasts and exclusive content, branded faidrRadio, which includes new artist discovery, curated music stations, and Music Casts. Music Casts are unique to faidr. Hosts and DJs can combine on-demand talk segments with dynamic music streaming, which allows users to hear podcasts with full music track plays embedded in the episodes.

Auddia has also developed a podcasting platform that provides a unique suite of tools that helps Podcasters create additional digital content for their podcast episodes as well as plan their episodes, build their brand, and monetize their content with new content distribution channels. This podcast platform also gives users the ability to go deeper into the stories through supplemental, digital content, and eventually comment and contribute their own content to episode feeds.

Both of Auddia’s offerings address large and rapidly growing audiences.

The Company has developed its AI platform on top of Google’s TensorFlow open-source library that is being “taught” to know the difference between all types of audio content on the radio. For instance, the platform recognizes the difference between a commercial and a song and is learning the differences between all other content to include weather reports, traffic, news, sports, DJ conversation, etc. Not only does the technology learn the differences between the various types of audio segments, but it also identifies the beginning and end of each piece of content.

The Company is leveraging this technology platform within its premium AM/FM radio listening experience through the faidr App. The faidr App is intended to be downloaded by consumers who will pay a subscription fee in order to listen to any streaming AM/FM radio station without commercials, podcasts and the faidrRadio exclusive content offerings. Advanced features will allow consumers to skip any content heard on the station, request audio content on-demand, and program an audio routine. We believe the faidr App represents a significant differentiated audio streaming product, or Superapp, that will be the first to come to market since the emergence of popular streaming music apps such as Pandora, Spotify, Apple Music, Amazon Music, etc. We believe that the most significant point of differentiation is that in addition to ad-free AM/FM streaming, the faidr App is intended to deliver non-music content that includes local sports, news, weather, traffic and the discovery of new music alongside exclusive programming and podcasts. No other radio streaming app available today, including category leaders like TuneIn, iHeart, and Audacy, can compete with faidr’s full product offerings.

We launched an MVP version of faidr through several consumer trials in 2021 to measure consumer interest and engagement with the App. The full app launched on February 15, 2022, and included all major U.S. radio stations in the US. In February 2023, we added faidrRadio, our exclusive content offerings, to the app. Podcasts were added to the app for the iOS version before the end of Q1 2023 as planned and added to the Android app in May of 2023. Podcast functionality will continue to be enhanced through 2023 and into 2024.

The Company has also developed its podcasting platform, which leverages technologies and proven product concepts to differentiate its podcasts offering from other competitors in the radio streaming product category.

With podcasting growing and predicted to grow at a rapid rate, the Auddia podcast platform was conceptualized to fill a void in the emerging audio media space. The platform aims to be the preferred podcasting solution for podcasters by enabling them to deliver digital content feeds that match the audio of their podcast episodes, and by enabling podcasters to make additional revenue from new digital advertising channels; subscription channels; on-demand fees for exclusive content; and through direct donations from their listeners. Today, podcasters do not have a preference as to where their listeners access their episodes, as virtually all listening options (mobile apps and web players) deliver only their podcast audio. By creating a platform on which they can make net new and higher margin revenue, we believe that podcasters will promote faidr to their listeners, thus creating a powerful, organic marketing dynamic.

One innovative and proprietary part of the podcast platform is the availability of tools to create and distribute an interactive digital feed which supplements podcast episode audio with additional digital. These content feeds allow podcasters to tell deeper stories to their listeners while giving podcasters access to digital revenue for the first time. Podcasters will be able to build these interactive feeds using The Podcast Hub, a content management system that also serves as a tool to plan and manage podcast episodes. The digital feed activates a new digital ad channel that turns every audio ad into a direct-response, relevant-to-the-story, digital ad, increasing the effectiveness and value of their established audio ad model. The feed also presents a richer listening experience, as any element of a podcast episode can be supplemented with images, videos, text and web links. This feed will appear fully synchronized in the faidr mobile App, and it also can be hosted and accessed independently (e.g., through any browser), making the content feed universally distributable.

Over time, users will be able to comment, and podcasters will be able to grant some users publishing rights to add content directly into the feed on their behalf. This will create another first for podcasting, a dialog between creator and fan, synchronized to the episode content.

The podcast capabilities within faidr will also introduce a unique and industry first multi-channel, highly flexible set of revenue channels that podcasters can activate in combination to allow listeners to choose how they want to consume and pay for content. “Flex Revenue” allows podcasters to continue to run their standard audio ad model and complement those ads with direct response enabled digital ads in each episode content feed, increasing the value of advertising on any podcast. “Flex Revenue” will also activate subscriptions, on-demand fees for content (e.g., listen without audio ads for a micro payment fee) and direct donations from listeners. Using these channels in combination, podcasters can maximize revenue generation and exercise higher margin monetization models, beyond basic audio advertising. Flex Revenue and the initial inclusion of the new revenue channels that come with it will be added to podcasting in the faidr app, and the first elements of this new monetization capability is expected to be commercially available before the end of 2023.

The faidr mobile App is available today through the iOS and Android App stores.

We have funded our operations with proceeds from the February 2021 IPO, Series A warrants exercised in July 2021 and common share issuance during June of 2023. We also obtained debt financing through a related party during November 2022 and April 2023. In addition, we sold common shares during April 2023 and June 2023. Since its inception, we have incurred significant operating losses. Since inception we have incurred significant operating losses. As of September 30, 2023, we had an accumulated deficit of $78.3 million. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development and commercialization of one or more of our Apps. We expect that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we:

	·	nationally launch our faidr App and as we continue training our proprietary AI technology and make product enhancements;
	·	continue to develop and expand our technology and functionality to advance the faidr app;
	·	rollout our product on a national basis, which will include increasing our sales and marketing costs related to the promotion of our products. faidr promotion will include a combination of a) purchasing ads directly from broadcasters or b) participating broadcasters to promote without purchasing ads, but sharing a portion of subscription proceeds based on listening activity on those stations;
	·	hire additional business development, product management, operational and marketing personnel;
	·	continue market studies of our products; and
	·	add operational and general administrative personnel which will support our product development programs, commercialization efforts and our transition to operating as a public company.

As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates.

Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.

As of September 30, 2023, we had cash of $2,199,678. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. However, if we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

To accelerate user acquisition, revenue, and cash flow, the Company has explored numerous potential acquisition targets of AM/FM streaming aggregators over the past year and a half and continues to explore new opportunities. At present, the Company is in advanced active discussions with two properties and is targeting to execute one or more agreements in the near term. These business development transactions would require additional funding.

Recent Developments

Nasdaq Deficiency Notices

On May 23, 2023, we received a letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, based upon the Company’s reported stockholders’ equity of $2,095,247 at the end of March 31, 2023, we are not in compliance with the requirement to maintain a minimum stockholders’s equity of $2,500,000 for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1) the “Stockholder’s Equity Requirement”). We were provided a compliance period of 45 calendar days from the date of the Notice, or until July 7, 2023, to submit a plan to regain compliance with the Stockholder’s Equity Requirement, pursuant to Nasdaq Listing Rule 5810(c)(2)(A).

The Company intends to consider all options to regain and maintain compliance with all Nasdaq continued listing requirements.

The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

Impact of Inflation

We have recently experienced higher costs across our business as a result of inflation, including higher costs related to employee compensation and outside services. We expect inflation to continue to have a negative impact throughout 2023, and it is uncertain whether we will be able to offset the impact of inflationary pressures in the near term.

Components of our results of operations

Operating expenses

Direct costs of services

Direct cost of services consists primarily of costs incurred related to our technology and development of our Apps, including hosting and other technology related expenses. We expect our direct costs of services to increase in the future as we continue to develop and enhance our technology related to the faidr and podcasting Apps.

Sales and marketing

Our sales and marketing expenses consist primarily of salaries, direct to consumer promotional spend and consulting services, all of which are related to the sales and promotion performed during the period. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscription conversion.

Research and development

Since our inception, we have focused significant resources on our research and development activities related to the software development of our technology. We account for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. We cease capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by our management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are impaired and expensed during the period of such determination. We expect to continue to incur research and development expenses and capitalization in the future as we continue to develop and enhance our faidr and podcasting Apps.

General and administrative

Our general and administrative expenses consist primarily of salaries and related costs, including payroll taxes, benefits, stock-based compensation, and professional fees related to auditing, tax, general legal services, and consulting services. We expect our general and administrative expenses to continue to increase in the future as we right-size our operating activities and prepare for commercialization of our products and support our operations as a public company, including increased expenses related to legal, accounting, insurance, regulatory and tax-related services associated with maintaining compliance with exchange listing and Securities and Exchange Commission requirements, directors and officers liability insurance premiums and investor relations activities.

Other income and expense

The other income and expense category primarily consists of interest expense attributed to the debt and conversion features of the Secured Bridge Note (aka the Prior Note). We expect our other expense to fluctuate period by period dependent upon either the payoff of the Prior Note or an extension of its term.

Results of operations

Comparison of the three months ended September 30, 2023, and 2022

The following table summarizes our results of operations:

	Three Months Ended
	September 30, 2023			September 30, 2022			Change $
Revenue	$	–		$	–

Operating expenses:
Direct cost of services		43,470			32,712			10,758
Sales and marketing		316,297			298,924			17,373
Research and development		227,133			181,596			45,537
General and administrative		777,496			540,220			237,276
Depreciation and amortization		465,166			274,839			190,327
Total operating expenses		1,829,562			1,328,291			501,271
Loss from operations		(1,829,562	)		(1,328,291	)		(501,271	)

Other (expense) income:
Interest expense		(286,920	)		(2,023	)		(284,897	)
Total other expense		(286,920	)		(2,023	)		(284,897	)

Loss before income taxes		(2,116,482	)		(1,330,314	)		(786,168	)
Provision for income taxes		–			–			–
Net loss	$	(2,116,482	)	$	(1,330,314	)		(786,168	)

Revenue

Total revenues for the three months ended September 30, 2023, and 2022 were $0 as we continue to develop and enhance our faidr and podcasting Apps to establish new revenue streams.

Direct cost of services

Direct Cost of Services increased $10,758 or 32.9% from $32,712 for the three months ended September 30, 2022, compared to $43,470 for the three months ended September 30, 2023. This increase was primarily the result of a slight increase in both platform hosting costs and other music services.

Sales and marketing

Sales and marketing expenses increased by $17,373 or 5.8%, from $298,924 for the three months ended September 30, 2022, to $316,297 for the three months ended September 30, 2023, primarily attributed to increased marketing and promotions costs as compared to Q3 2022. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscription conversion.

Research and development

Research and development expenses increased by $45,537 or 25.1%, from $181,596 for the three months ended September 30, 2022, to $227,133 for the three months ended September 30, 2023, primarily related to slightly increased staffing cost. We are continually developing enhancements to both our faidr and podcasting Apps and will continue capitalize software costs to the extent that such development qualifies for capitalization.

General and administrative

General and administrative expenses increased by $237,276 or 43.9%, from $540,220 for the three months ended September 30, 2022, compared to $777,496 for the three months ended September 30, 2023. The increase resulted from an increase in stock compensation expense compared to Q3 2022.

Depreciation and amortization

Depreciation and amortization expenses increased by $190,327 or 69.3%, from $274,839 for the three months ended September 30, 2022, compared to $465,166 for the three months ended September 30, 2023. The increase is entirely related to the increased amortization of our faidr and podcasting Apps.

Other income (expense), net

Total other expenses increased by $284,897, from $2,023 for the three months ended September 30, 2022, to $286,920 for the three months ended September 30, 2023. The increase is related to actual and imputed interest expense attributed to the Secured Bridge Notes issued during November of 2022 and April 2023 (Refer to Note 4 of the condensed unaudited financial statements for additional information regarding the secured bridge notes).

Comparison of the nine months ended September 30, 2023, and 2022

	Nine Months Ended
	September 30, 2023			September 30, 2022			Change $
Revenue	$	–		$	–

Operating expenses:
Direct cost of services		130,809			128,806			2,003
Sales and marketing		765,176			1,396,010			(630,834	)
Research and development		617,622			481,611			136,011
General and administrative		2,596,831			2,400,503			196,328
Depreciation and amortization		1,350,820			721,971			628,849
Total operating expenses		5,461,258			5,128,901			332,357
Loss from operations		(5,461,258	)		(5,128,901	)		(332,357	)

Other (expense) income:
Interest expense		(1,133,398	)		(5,058	)		(1,128,340	)
Total other expense		(1,133,398	)		(5,058	)		(1,128,340	)

Loss before income taxes		(6,594,656	)		(5,133,959	)		(1,460,697	)
Provision for income taxes		–			–			–
Net loss	$	(6,594,656	)	$	(5,133,959	)		(1,460,697	)

Revenue

Total revenues for the nine months ended September 30, 2023, and 2022 were $0 as we continue to develop and enhance our faidr and podcasting Apps to establish new revenue streams.

Direct cost of services

Direct Cost of Services increased $2,003 or 1.6% from $128,806 for the nine months ended September 30, 2022, compared to $130,809 for the nine months ended September 30, 2023. This increase was primarily the result of a slight increase in both platform hosting costs and other music services.

Sales and marketing

Sales and marketing expenses decreased by $630,834 or 45.2%, from $1,396,010 for the nine months ended September 30, 2022, to $765,176 for the nine months ended September 30, 2023, primarily attributed to reduced staffing, consulting expense, and marketing and promotions costs as compared to the nine months ended September 30, 2022 that were associated with the national launch of the faidr App. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscription conversion.

Research and development

Research and development expenses increased by $136,011 or 28.2%, from $481,611 for the nine months ended September 30, 2022, to $617,622 for the nine months ended September 30, 2023, primarily related to increased staffing, and an associated reduction in the level of capitalized software expenses. We are continually developing enhancements to both our faidr and podcasting Apps and will continue capitalize software costs to the extent that such development qualifies for capitalization.

General and administrative

General and administrative expenses increased by $196,328 or 8.2%, from $2,400,503 for the nine months ended September 30, 2022, compared to $2,596,831 for the nine months ended September 30, 2023. The increase resulted from an increase in stock compensation expense compared to 2022.

Depreciation and amortization

Depreciation and amortization expenses increased by $628,849 or 87.1%, from $721,971 for the nine months ended September 30, 2022, compared to $1,350,820 for the nine months ended September 30, 2023. The increase is entirely related to the increased amortization of our faidr and podcasting Apps.

Other income (expense), net

Total other expense increased by $1,128,340, from $5,058 for the nine months ended September 30, 2022, to $1,133,398 for the nine months ended September 30, 2023. The increase is related to interest expense attributed to the Secured Bridge Notes issued during November of 2022 and April of 2023, which included the finance charges associated with debt issuance cost (refer to Note 4 of the condensed unaudited financial statements for additional information regarding the secured bridge notes).

Liquidity and capital resources

Sources of liquidity

We have incurred operating losses since our inception and have an accumulated deficit as a result of ongoing efforts to develop and commercialize our faidr and podcasting Apps. As of September 30, 2023, and December 31, 2022, we had cash of $2,199,678 and $1,661,434, respectively. We have a deficit in working capital in the amount of approximately $1.4 million at September 30, 2023. We anticipate that operating losses and net cash used in operating activities will increase over the next 12 months as we continue to develop and market our products. Our existing cash of $2.2 million at September 30, 2023 will only be sufficient to fund our current operating plans into February 2024. The Company has based these estimates, however, on assumptions that may prove to be wrong. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

We had cash on hand of $2,199,678 as of September 30, 2023. The Company will need to raise additional funds to continue funding our technology development and commercialization efforts beyond such time. Management intends to secure such funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

Interim Bridge Financings

As previously disclosed, we entered into a Secured Bridge Note (“Prior Note”) financing on November 14, 2022 with one of our accredited investors who is a significant existing shareholder of the Company. We received $2,000,000 of gross proceeds in connection with that financing.

On April 17, 2023, we entered into an additional Secured Bridge Note (“New Note”) financing with the same accredited investor. We received $750,000 of gross proceeds in connection with the New Note financing. The principal amount of the New Note is $825,000. The New Note has a 10% interest rate and matures on July 31, 2023. The New Note is secured by a lien on substantially all of our assets. At maturity, the lender has the option to convert any original issue discount and accrued but unpaid interest on the New Note into shares of our common stock. The fixed conversion price is $0.61 per share.

In connection with the New Note financing, we issued 650,000 common stock warrants to the investor with a five-year term and a fixed $0.61 per share exercise price. 325,000 of such warrants are exercisable immediately. The other 325,000 of such warrants would only become exercisable if the maturity date of the New Note is extended in accordance with the terms of the New Note. Further, if the New Note remains outstanding as of July 31, 2023, we have the option to extend the maturity date of the New Note to November 30, 2023. Upon such extension, the interest rate on the New Note will be increased to 20% from 10%, and the 325,000 portion of the warrants shall become exercisable.

Further, in connection with the New Note financing, the parties agreed to make certain amendments to the Prior Note financing. Specifically, the parties agreed to cancel the 300,000 common stock warrants issued as part of the prior financing and, in lieu of the cancelled warrants, issued the investor common stock warrants for 600,000 common shares with an exercise price of $0.61 per common share and a five-year term. 300,000 of such warrants were exercisable immediately, while the other 300,000 warrants became exercisable upon the maturity date extension of the Prior Note during May of 2023.

The investor will not be able to receive shares upon conversion or exercise, unless prior shareholder approval is obtained, if the number of shares to be issued to the investor, when aggregated with all other shares of common stock then owned by the investor beneficially or deemed beneficially owned by the investor, would (i) result in the investor owning more than the Beneficial Ownership Limitation (as defined below), as determined in accordance with Section 13 of the Securities Exchange Act of 1934 or (ii) otherwise constitute a Change of Control within the meaning of Nasdaq Rule 5635(b). The “Beneficial Ownership Limitation” shall be 19.99% of the number of shares of the common stock outstanding immediately prior to the proposed issuance of shares of common stock.

Equity Line Sales of Common Stock

On November 14, 2022, we entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility.

On April 17 and April 20, 2023, we closed on two sales of Common Stock under the White Lion Purchase Agreement. We issued an aggregate of 1,962,220 common shares and received aggregate proceeds of approximately $1.12 million.

Cash Flow Analysis

Our cash flows from operating activities have historically been significantly impacted by our investment in sales and marketing to drive growth, and research and development expenses. Our ability to meet future liquidity needs will be driven by our operating performance and the extent of continued investment in our operations. Failure to generate sufficient revenues and related cash flows could have a material adverse effect on our ability to meet our liquidity needs and achieve our business objectives.

The following table summarizes the statements of cash flows for the nine months ended September 30, 2023, and 2022:

	Nine Months Ended September 30,
	2023			2022
Net cash provided by (used in):
Operating activities	$	(3,404,954	)	$	(3,622,112	)
Investing activities		(743,208	)		(1,677,326	)
Financing activities		4,686,406			(88,723	)
Change in cash	$	538,244		$	(5,388,161	)

Operating activities

Cash used in operating activities for the nine months ended September 30, 2023, was ($3,404,954), primarily resulting from our net loss of ($6,594,656) and change in working capital of $188,517 related to an increase in accounts payable and accrued liabilities, offset by non-cash charges of $3,001,184 related to depreciation and amortization, share based compensation expense, and finance charges associated with the debt issuance costs of the Secured Bridge Notes. Cash used in operating activities for both periods consisted of personnel-related expenditures, marketing and promotion costs, and public company administrative support costs such as legal and other professional support services.

Investing activities

Cash flows used in investing activities for the nine months ended September 30, 2023, was $743,208, consisting entirely of capitalization of software development expenses.

Cash flows used in investing activities for the nine months ended September 30, 2022, was $1,677,326, primarily consisting of capitalization of software development expenses of $1,673,517 and purchase of property and equipment of $3,809.

Financing activities

Cash flows generated in financing activities for the nine months ended September 30, 2023, was $4,686,406 and related primarily to cash proceeds from the issuance of common shares of $4,016,521 and proceeds from related party debt of $750,000.

Cash flows used in financing activities for the nine months ended September 30, 2022, was $88,723 related to cash paid by the Company related to the net-share settlement of vested restricted stock units during the quarter.

Funding Requirements

We historically have incurred significant losses and negative cash flows from operations since our inception and had an accumulated deficit of $78.3 million and $71.7 million as of September 30, 2023, and December 31, 2022, respectively. As of September 30, 2023, and December 31, 2022, we had cash of $2,199,678 and $1,661,434, respectively. Our cash is comprised primarily of demand deposit accounts and money market funds. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the development, and marketing and promotion of faidr. In addition, we expect to continue to incur additional costs associated with operating as a public company, including legal, accounting, investor relations and other expenses. Our future funding requirements will depend on many factors, including, but not limited to:

	·	the scope, progress, results, and costs related to the market acceptance of our products
	·	the ability to attract podcasters and content creators to faidr and retain listeners on the platform
	·	the costs, timing, and ability to continue to develop our technology
	·	effectively addressing any competing technological and market developments
	·	avoiding and defending against intellectual property infringement, misappropriation and other claims

Contractual Obligations

The following table summarizes our contractual obligations not on our Balance Sheet as of September 30, 2023, and the effects that such obligations are expected to have on our liquidity and cash flows in future periods:

	Payments due by period
	Total		Less Than 1 Year		1 - 3 Years		4 - 5 Years		More Than 5 Years
Operating lease commitments:
Office lease⁽¹⁾	$	25,000	$	25,000	$	–	$	–	$	–
Insurance premiums ⁽²⁾		18,000		18,000		–		–		–
Total operating lease commitments	$	43,000	$	43,000	$	–	$	–	$	–

(1)	Represents minimum payments due for the lease of office space.
(2)	Represents premium payments due related to D&O insurance policy from February 2023 – February 2024

Off-balance sheet arrangements

We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

Critical Accounting Estimates

Our condensed financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these condensed financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we continually evaluate our estimates and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results may materially differ from these estimates made by management under different assumptions and conditions.

Our critical accounting estimates are presented in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with SEC on March 23, 2023. There were no material changes to our critical accounting estimates during the nine months ended September 30, 2023.

Emerging growth company and smaller reporting company status

The Jumpstart Our Business Startups Act of 2012 permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to not “opt out” of this provision and, as a result, we will adopt new or revised accounting standards at the time private companies adopt the new or revised accounting standard and will do so until such time that we either (i) irrevocably elect to “opt out” of such extended transition period or (ii) no longer qualify as an emerging growth company.

We are also a “smaller reporting company” meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were not effective at a reasonable assurance level due to the material weaknesses in internal control over financial reporting described below. The Company’s disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Changes in Internal Control Over Financial Reporting

Management has been actively engaged in remediating the material weaknesses discussed in our Form 10-K for the period ended December 31, 2022 filed with SEC on March 23, 2023. The following remedial actions have been taken during the quarter ended September 30, 2023:

	·	continue to strengthen our internal policies, processes, and reviews, including drafting of related documentation thereof;
	·	continue to engage outside consultants to ensure that appropriate level of knowledge and experience is applied based on risk and complexity of transactions and tasks under review;
	·	complete the internal control documentation with our consultants who have been engaged to assist in the design, implementation, and documentation of internal controls to address the relevant risks;
	·	engaged an outside internal control specialist team to perform a robust review of the design and implementation of internal controls; and
	·	hired additional accounting resources with appropriate levels of experience

The process of implementing an effective financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a financial reporting system that is adequate to satisfy our reporting obligations. As we continue to evaluate and take actions to improve our internal control over financial reporting, we may take additional actions to address control deficiencies or modify certain of the remediation measures described above.

While progress has been made to enhance our internal control over financial reporting, we are still in the process of implementing these processes, procedures, and controls. Additional time is required to complete this phase and to assess and ensure the sustainability of these procedures. We believe the above actions will be effective in remediating the material weaknesses described above and we will continue to devote significant time and attention to these remedial efforts.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

From time to time, we are involved in various disputes, claims, suits, investigations, and legal proceedings arising in the ordinary course of business. We believe that the resolution of current pending legal matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Nonetheless, we cannot predict the outcome of these proceedings, as legal matters are subject to inherent uncertainties, and there exists the possibility that the ultimate resolution of these matters could have a material adverse effect on our business, financial condition, results of operations or cash flows. For additional information, see “Note 5. Commitments and Contingencies” to our financial statements included in this Form 10-Q.

Item 1A.

Risk Factors

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors disclosed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022. Except as set forth below, there have been no material changes to our risk factors from those included in our Annual Report on Form 10-K for the year ended December 31, 2022.

Our recently announced growth strategy includes seeking acquisitions of other companies or assets in our industry sector. We may not be successful in identifying, making and integrating business or asset acquisitions, if any, in the future.

As announced in April 2023, we anticipate that a component of our growth strategy may be to make strategically focused acquisitions of businesses or assets. Pursuit of this strategy may be restricted by the on-going volatility and uncertainty within the capital markets which may significantly limit the availability of funds for such acquisitions. Our ability to use shares of our common stock in an acquisition transaction may be adversely affected by the volatility in the price of our common stock and by the potential requirement of shareholder approval under applicable Nasdaq listing rules.

In addition to restricted funding availability, the success of our recently announced strategy will depend on our ability to identify suitable acquisition candidates and to negotiate acceptable financial and other terms. There is no assurance that we will be able to do so. The success of an acquisition also depends on our ability to perform adequate due diligence before the acquisition and on our ability to integrate the acquisition after it is completed. While we intend to commit significant resources to ensure that we conduct comprehensive due diligence, there can be no assurance that all potential risks and liabilities will be identified in connection with an acquisition. Similarly, while we expect to commit substantial resources, including management time and effort, to integrating acquired businesses into ours, there is no assurance that we will be successful in integrating these businesses. If we fail in performing adequate due diligence or in successfully integrating acquired businesses, our future operations would be negatively impacted.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Issuer Purchases of Equity Securities

We did not repurchase any of our equity securities during the three months ended September 30, 2023.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None.

Item 6.

Exhibits

The exhibits required by Item 601 of Regulation S-K and Item 15(b) of this Quarterly Report are listed in the Exhibit Index below. The exhibits listed in the Exhibit Index are incorporated by reference herein.

Exhibit Number		Description of Document	Incorporated by reference from Form	Filing Date	Exhibit Number	Filed Herewith

2.2		Form of Plan of Conversion	8-K	02-22-2021	2.1
3.1		Certificate of Incorporation of the Company	8-K	02-22-2021	3.1
3.2		Bylaws of the Company	8-K	02-22-2021	3.2
3.3		Form of Warrant after Conversion from an LLC to a Corporation	S-1/A	01-28-2020	3.5
3.4		Form of Series A Warrant	S-1/A	02-05-2021	3.6
4.1		Form of Common Stock Certificate	S-1/A	10-08-2020	4.1
4.2		Form of Representative’s Common Stock Purchase Warrant	8-K	02-22-2021	4.1
4.3		Description of Securities	10-K	03-31-2021	4.3
10.1	#	Employment Agreement of Michael T. Lawless	S-1	01-10-2020	10.1
10.2	#	Employment Agreement of Peter Shoebridge	S-1	01-10-2020	10.2
10.3	#	Form of Auddia Inc. 2020 Equity Incentive Plan	S-1/A	10-22-2020	10.3
10.4		Collateral and Security Agreement with Related Party (Minicozzi)	S-1/A	01-28-2020	10.4
10.5		Form of Amendment to Collateral and Security Agreement with Related Party	S-1/A	10-08-2020	10.5
10.6		Form of Convertible Promissory Note	S-1/A	01-28-2020	10.6
10.7		Business Loan Agreement and Guaranty of Related Party with Bank of the West	S-1/A	01-28-2020	10.7
10.8	**	Agreement with Major United States Broadcast Company	S-1/A	01-28-2020	10.8
10.9		Form of Bridge Note	S-1/A	10-22-2020	10.9
10.10		Form of Warrant Agent Agreement	S-1/A	02-05-2021	10.10
10.11		Amendment to Bridge Note	S-1/A	10-22-2020	10.14
10.12		Amended Business Loan Agreement with Bank of the West	10-K	03-31-2021	10.15

10.13	#	First Amendment to 2020 Equity Incentive Plan	S-8	08-10-2021	99.2
10.14	#	Form of Stock Option Grant Notice and Stock Option Agreement under 2020 Equity Incentive Plan	S-8	08-10-2021	99.3
10.15	#	Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2020 Equity Incentive Plan	S-8	08-10-2021	99.4
10.16	#	Form of Inducement Stock Option Grant Notice and Inducement Stock Option Agreement	S-8	08-10-2021	99.5
10.17	#	Clip Interactive, LLC 2013 Equity Incentive Plan	S-8	08-10-2021	99.6
10.18	#	Form of Stock Option Grant Notice and Stock Option Agreement under 2013 Equity Incentive Plan	S-8	08-10-2021	99.7
10.19	#	Executive Officer Employment Agreement for Michael Lawless dated October 13, 2021	8-K	10-15-2021	10.1
10.20	#	Executive Officer Employment Agreement for Peter Shoebridge dated October 13, 2021	8-K	10-15-2021	10.2
10.21	#	Executive Officer Employment Agreement for Brian Hoff dated October 13, 2021	8-K	10-15-2021	10.3
10.22	#	Executive Officer Employment Agreement for Timothy Ackerman effective as of February 6, 2023	8-K	02-16-2023	10.1
10.23		Secured Promissory Bridge Note dated November 14, 2022	8-K	11-14-2022	10.1
10.24		Common Stock Warrant dated November 14, 2022	8-K	11-14-2022	10.2
10.25		Security Agreement dated November 14, 2022	8-K	11-14-2022	10.3
10.26		Common Stock Purchase Agreement, dated November 14, 2022, by and between Auddia Inc. and White Lion Capital LLC	8-K	11-14-2022	10.4
10.27		Secured Promissory Bridge Note dated April 17, 2021	8-K	04-21-2023	10.1
10.28		Common Stock Warrant for 600,000 shares dated April 17, 2023	8-K	04-21-2023	10.2
10.29		Common Stock Warrant for 650,000 shares dated April 17, 2023	8-K	04-21-2023	10.3
10.30		Form of Private Placement Agreement	8-K	06-14-23	1.1
10.31		Form of Securities Purchase Agreement dated June 13, 2023 between Auddia Inc. and the Investors named therein	8-K	06-14-23	10.1
10.32		Common Stock Purchase Agreement, dated as of November 6, 2023, by and between White Lion Capital, LLC and Auddia Inc.	8-K	11-06-23	10.1
10.33		Registration Rights Agreement, dated as of November 6, 2023, by and between White Lion Capital, LLC and Auddia Inc.	8-K	11-06-23	10.2
31.1		Section 302 Certification by the Corporation’s Chief Executive Officer and Interim Chief Financial Officer				X
32.1		Section 906 Certification by the Corporation’s Chief Executive Officer and Interim Chief Financial Officer				X

101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

___________________________

#	Indicates management contract or compensatory plan.
**	Certain information contained in this Exhibit has been redacted and appears as “XXXXX” as the disclosure of same would be a disadvantage to the Registrant in the marketplace

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AUDDIA INC.

	By:	/s/ Michael Lawless
		Michael Lawless President, Chief Executive Officer, Interim Chief Financial Officer and Director

Date: November 14, 2023

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) OR 15D-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Michael Lawless, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2023, of Auddia Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 14, 2023

/s/ Michael Lawless

Michael Lawless

Chief Executive Officer and Interim Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Auddia Inc. (the “Company”) on Form 10-Q, for the period ended September 30, 2023, as filed with the Securities and Exchange Commission, I, Michael Lawless, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

November 14, 2023

/s/ Michael Lawless

Michael Lawless

Chief Executive Officer and Interim Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2023	Nov. 13, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-40071
Entity Registrant Name	AUDDIA INC.
Entity Central Index Key	0001554818
Entity Tax Identification Number	45-4257218
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2100 Central Ave.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Boulder
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80301
City Area Code	(303)
Local Phone Number	219-9771
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		19,947,223
Common Stock, par value $0.001 per share
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AUUD
Security Exchange Name	NASDAQ
Warrants, each exercisable for one share of Common Stock
Title of 12(b) Security	Warrants, each exercisable for one share of Common Stock
Trading Symbol	AUUDW
Security Exchange Name	NASDAQ

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 2,199,678	$ 1,661,434
Accounts receivable, net	574	137
Prepaid insurance	56,704	0
Total current assets	2,256,956	1,661,571
Non-current assets:
Property and equipment, net of accumulated depreciation	22,084	41,080
Software development costs, net of accumulated amortization	3,545,610	4,134,225
Deferred offering costs	170,259	222,896
Prepaids and other non-current assets	47,364	51,754
Total non-current assets	3,785,317	4,449,955
Total assets	6,042,273	6,111,526
Current liabilities:
Accounts payable and accrued liabilities	587,641	324,138
Notes payable to related party, net of debt issuance costs	2,993,639	1,775,956
Stock awards liability	45,981	161,349
Total current liabilities	3,627,261	2,261,443
Total liabilities	3,627,261	2,261,443
Commitments and contingencies (Note 5)
Shareholders' equity:
Preferred stock - $0.001 par value, 10,000,000 authorized and 0 shares issued and outstanding	0	0
Common stock - $0.001 par value, 100,000,000 authorized and 19,947,223 and 12,654,949 shares issued and outstanding September 30, 2023 and December 31, 2022	19,947	12,654
Additional paid-in capital	80,725,555	75,573,263
Accumulated deficit	(78,330,490)	(71,735,834)
Total shareholders' equity	2,415,012	3,850,083
Total liabilities and shareholders' equity	$ 6,042,273	$ 6,111,526

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	19,947,223	12,654,949
Common stock, shares outstanding	19,947,223	12,654,949

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Direct cost of services	43,470	32,712	130,809	128,806
Sales and marketing	316,297	298,924	765,176	1,396,010
Research and development	227,133	181,596	617,622	481,611
General and administrative	777,496	540,220	2,596,831	2,400,503
Depreciation and amortization	465,166	274,839	1,350,820	721,971
Total operating expenses	1,829,562	1,328,291	5,461,258	5,128,901
Loss from operations	(1,829,562)	(1,328,291)	(5,461,258)	(5,128,901)
Other (expense) income:
Interest expense	(286,920)	(2,023)	(1,133,398)	(5,058)
Total other expense	(286,920)	(2,023)	(1,133,398)	(5,058)
Loss before income taxes	(2,116,482)	(1,330,314)	(6,594,656)	(5,133,959)
Provision for income taxes	0	0	0	0
Net loss	$ (2,116,482)	$ (1,330,314)	$ (6,594,656)	$ (5,133,959)

Condensed Statements of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net loss per share attributable to common stockholders, basic	$ (0.11)	$ (0.11)	$ (0.41)	$ (0.41)
Net loss per share attributable to common stockholders, diluted	$ (0.11)	$ (0.11)	$ (0.41)	$ (0.41)
Weighted average common shares outstanding, basic	19,947,223	12,514,763	16,043,086	12,498,206
Weighted average common shares outstanding, diluted	19,947,223	12,514,763	16,043,086	12,498,206

Condensed Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 12,416	$ 74,236,910	$ (64,838,389)	$ 9,410,937
Beginning balance, shares at Dec. 31, 2021	12,416,408
Exercise of Restricted Stock Units	$ 98	(98)
Exercise of Restricted Stock Units, shares	98,355
Share-based compensation		385,908		385,908
Reclassification of share-based compensation liability		(128,534)		(128,534)
Net loss			(1,753,258)	(1,753,258)
Ending balance, value at Mar. 31, 2022	$ 12,514	74,494,186	(66,591,647)	7,915,053
Ending balance, shares at Mar. 31, 2022	12,514,763
Beginning balance, value at Dec. 31, 2021	$ 12,416	74,236,910	(64,838,389)	9,410,937
Beginning balance, shares at Dec. 31, 2021	12,416,408
Net loss				(5,133,959)
Ending balance, value at Sep. 30, 2022	$ 12,514	74,727,187	(69,972,348)	4,767,353
Ending balance, shares at Sep. 30, 2022	12,514,763
Beginning balance, value at Mar. 31, 2022	$ 12,514	74,494,186	(66,591,647)	7,915,053
Beginning balance, shares at Mar. 31, 2022	12,514,763
Share-based compensation		285,921		285,921
Reclassification of share-based compensation liability		(7,262)		(7,262)
Net loss			(2,050,385)	(2,050,385)
Ending balance, value at Jun. 30, 2022	$ 12,514	74,772,845	(68,642,032)	6,143,327
Ending balance, shares at Jun. 30, 2022	12,514,763
Share-based compensation		26,657		26,657
Revaluation of share-based compensation liability		(72,315)		(72,315)
Net loss			(1,330,314)	(1,330,314)
Ending balance, value at Sep. 30, 2022	$ 12,514	74,727,187	(69,972,348)	4,767,353
Ending balance, shares at Sep. 30, 2022	12,514,763
Beginning balance, value at Dec. 31, 2022	$ 12,654	75,573,262	(71,735,834)	3,850,083
Beginning balance, shares at Dec. 31, 2022	12,654,949
Exercise of Restricted Stock Units	$ 196	42,601		42,797
Exercise of Restricted Stock Units, shares	195,760
Share-based compensation		357,680		357,680
Net loss			(2,155,312)	(2,155,312)
Ending balance, value at Mar. 31, 2023	$ 12,850	75,973,543	(73,891,146)	2,095,247
Ending balance, shares at Mar. 31, 2023	12,850,709
Beginning balance, value at Dec. 31, 2022	$ 12,654	75,573,262	(71,735,834)	3,850,083
Beginning balance, shares at Dec. 31, 2022	12,654,949
Net loss				(6,594,656)
Ending balance, value at Sep. 30, 2023	$ 19,947	80,725,555	(78,330,490)	2,415,012
Ending balance, shares at Sep. 30, 2023	19,947,223
Beginning balance, value at Mar. 31, 2023	$ 12,850	75,973,543	(73,891,146)	2,095,247
Beginning balance, shares at Mar. 31, 2023	12,850,709
Issuance of common shares, net of costs	$ 7,097	3,956,787		3,963,884
Issuance of common shares, net of costs, shares	7,096,514
Exercise of Restricted Stock Units		(42,797)		(42,797)
Issuance of warrants		383,004		383,004
Share-based compensation		224,856		224,856
Revaluation of share-based compensation liability		30,445		30,445
Net loss			(2,322,862)	(2,322,862)
Ending balance, value at Jun. 30, 2023	$ 19,947	80,525,838	(76,214,008)	4,331,777
Ending balance, shares at Jun. 30, 2023	19,947,223
Share-based compensation		217,141		217,141
Revaluation of share-based compensation liability		(17,424)		(17,424)
Net loss			(2,116,482)	(2,116,482)
Ending balance, value at Sep. 30, 2023	$ 19,947	$ 80,725,555	$ (78,330,490)	$ 2,415,012
Ending balance, shares at Sep. 30, 2023	19,947,223

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (6,594,656)	$ (5,133,959)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Finance charge associated with debt issuance cost	850,688	0
Depreciation and amortization	1,350,820	721,971
Share-based compensation expense	799,677	698,486
Change in assets and liabilities:
Accounts receivable	(437)	52
Prepaid insurance	(56,705)	0
Prepaids and other non-current assets	4,390	(1,065)
Accounts payable and accrued liabilities	241,269	92,403
Net cash used in operating activities	(3,404,954)	(3,622,112)
Cash flows from investing activities:
Software capitalization	(743,208)	(1,673,517)
Purchase of property and equipment	0	(3,809)
Net cash used in investing activities	(743,208)	(1,677,326)
Cash flows from financing activities:
Net settlement of share-based compensation liability	(80,115)	(88,723)
Proceeds from related party debt	750,000	0
Proceeds from issuance of common shares	4,016,521	0
Net cash provided by (used in) financing activities	4,686,406	(88,723)
Net increase in cash	538,244	(5,388,161)
Cash, beginning of year	1,661,434	6,345,291
Cash and restricted cash, end of period	2,199,678	957,130
Supplemental disclosures of cash flow information:
Cash paid for Interest	6,000	5,058
Supplemental disclosures of non-cash activity:
Reclassification of deferred offering cost	52,637	0
Original issue discount and issuance of warrants on related party debt	$ 458,004	$ 0

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

Note 1 - Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

Description of Business

Basis of Presentation

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

Interim Financial Information

Use of Estimates

Risks and Uncertainties

Emerging Growth Company Status

Going Concern

Cash

Software Development Costs

Revenue Recognition

Share-Based Compensation

Recently Adopted ASUs

Property & Equipment and Software Development Costs

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Property & Equipment and Software Development Costs

Note 2 – Property & Equipment and Software Development Costs

Property and equipment and software development costs consisted of the following as of:


	September 30, 2023			December 31, 2022

Computers and equipment	$	99,939		$	99,939
Furniture		7,263			7,262
Accumulated depreciation		(85,118	)		(66,121	)
Total property and equipment, net	$	22,084		$	41,080


Software development costs	$	7,369,257		$	6,626,049
Accumulated amortization		(3,823,647	)		(2,491,824	)
Total software development costs, net	$	3,545,610		$	4,134,225

Accounts Payable and Accrued Liabilities

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

Note 3 – Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following:


	September 30, 2023		December 31, 2022

Accounts payable and accrued liabilities	$	269,159	$	289,955
Credit cards payable		14,517		6,072
Accrued interest		303,965		28,111
	$	587,641	$	324,138

Notes Payable to Related Party, net of debt issuance costs

9 Months Ended

Sep. 30, 2023

Notes Payable to Related Party, net of debt issuance costs

Note 4 – Notes Payable to Related Party, net of debt issuance costs

On July 31, 2023, the Company extended the maturity date of the New Note to November 30, 2023. In connection with such extension, 325,000 outstanding unvested warrants became vested and exercisable.

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 5 – Commitments and Contingencies

Operating Lease

Litigation

NASDAQ Deficiencies

The Company intends to consider all options to regain and maintain compliance with all Nasdaq continued listing requirements.

The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

Share-based Issuances

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Share-based Issuances

Note 6 - Share-based Issuances

Stock Options

The following table presents the activity for stock options outstanding:

Schedule of stock option activity
	Options			Weighted Average Exercise Price
Outstanding - December 31, 2022		1,663,173		$	2.45
Granted		200,200			0.94
Forfeited/canceled		(206,454	)		1.51
Exercised		–			–
Outstanding - September 30, 2023		1,656,919		$	2.38

The following table presents the composition of options outstanding and exercisable:

	Options Outstanding				Options Exercisable
Exercise Prices	Number		Price	Life*	Number		Price*
$2.70	22,264	$	2.70	0.75	22,264	$	2.70
$2.90	53,128	$	2.90	4.11	53,128	$	2.90
$4.26	171,197	$	4.26	5.73	171,197	$	4.26
$2.79	772,194	$	2.79	7.23	553,122	$	2.79
$1.79	198,750	$	1.79	7.87	68,437	$	1.79
$1.21	389,386	$	1.21	8.95	292,039	$	1.21
$0.40	50,000	$	0.40	9.69	–	$	0.40
Total - September 30, 2023	1,656,919	$	2.38		1,160,187	$	2.59

*	Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

Restricted Stock Units

The following table presents the activity for restricted stock units outstanding:


	Restricted Stock Units			Weighted Average Grant Date Fair Value
Outstanding - December 31, 2022		563,859		$	2.14
Granted		37,500			1.24
Forfeited/canceled		(118,350	)		1.83
Vested/issued		(195,759	)		1.83
Outstanding - September 30, 2023		287,250		$	2.37

Warrants

The following table presents the activity for warrants outstanding:

Schedule of warrant outstanding
	Warrants		Weighted Average Exercise Price
Outstanding - December 31, 2022		4,472,099	$	4.62
Granted		950,000		0.61
Forfeited/canceled		–		–
Exercised		–		–
Outstanding - September 30, 2023		5,422,099	$	3.84

5,422,099 of the outstanding warrants are currently exercisable and have a weighted average remaining contractual life of approximately 2.69 years as of September 30, 2023.

Net Loss Per Share

9 Months Ended

Sep. 30, 2023

Net loss per share attributable to common stockholders

Net Loss Per Share

Note 7 – Net Loss Per Share

Equity Financings

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Equity Financings

Note 8 – Equity Financings

Equity Line Sales of Common Stock

Any proceeds that the Company receives under the White Lion Purchase Agreement are expected to be used for working capital and general corporate purposes.

The Company recognized all offering costs related to the equity line of credit as deferred offering costs in accordance with the guidance in ASC 835-30-S45.

Sale of Common Shares (S-3 offering)

In June 2023, the Company sold 4,735,000 shares of common stock in a registered public offering with net proceeds of $2.7 million.

Subsequent Events

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

Subsequent Events

Note 9 – Subsequent Events

Replacement Equity Line with White Lion

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Description of Business	Description of Business Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).
Interim Financial Information	Interim Financial Information The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2022 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company's common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.
Going Concern	Going Concern The Company had cash of $2,199,678 as of September 30, 2023. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company will be forced to delay, reduce, or eliminate technology development and commercialization efforts. As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 8) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand by February 2024.
Cash	Cash The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents as of September 30, 2023 or December 31, 2022. The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2023, the Company had approximately $1.9 million in excess of federally insured limits. As of December 31, 2022, the Company had approximately $1.4 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.
Software Development Costs	Software Development Costs The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. We determined that no such impairments were required during the three months and nine months ended September 30, 2023. Software development costs of $213,705 and $394,893 were capitalized for the three months ended September 30, 2023, and 2022, respectively and $743,208 and $1,673,517 were capitalized for the nine months ended September 30, 2023 and 2022, respectively. Amortization of capitalized software development costs were $458,973 and $262,703 for the three months ended September 30, 2023, and 2022, respectively and $1,331,823 and $693,441 for the nine months ended September 30, 2023 and 2022, respectively and are included in depreciation and amortization expense in the Company’s condensed statement of operations.
Revenue Recognition	Revenue Recognition Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority. Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions. Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.
Share-Based Compensation	Share-Based Compensation The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718. Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods. Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.
Recently Adopted ASUs	Recently Adopted ASUs ASU 2016-13-Financial Instruments-Credit Losses- The new guidance makes significant changes to the accounting for credit losses on financial instruments and disclosures about them. Specifically, the new CECL impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, that considers forecasts of future economic conditions in addition to information about past events and current conditions. The Company adopted the new standard beginning January 1, 2023. The adoption of the new standard did not have a material impact on the Company’s financial statements.

Property & Equipment and Software Development Costs (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Schedule of property, equipment and software development costs


	September 30, 2023			December 31, 2022

Computers and equipment	$	99,939		$	99,939
Furniture		7,263			7,262
Accumulated depreciation		(85,118	)		(66,121	)
Total property and equipment, net	$	22,084		$	41,080


Software development costs	$	7,369,257		$	6,626,049
Accumulated amortization		(3,823,647	)		(2,491,824	)
Total software development costs, net	$	3,545,610		$	4,134,225

Accounts Payable and Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Schedule of accounts payable and accrued liabilities


	September 30, 2023		December 31, 2022

Accounts payable and accrued liabilities	$	269,159	$	289,955
Credit cards payable		14,517		6,072
Accrued interest		303,965		28,111
	$	587,641	$	324,138

Share-based Issuances (Tables)

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Schedule of stock option activity

Schedule of stock option activity
	Options			Weighted Average Exercise Price
Outstanding - December 31, 2022		1,663,173		$	2.45
Granted		200,200			0.94
Forfeited/canceled		(206,454	)		1.51
Exercised		–			–
Outstanding - September 30, 2023		1,656,919		$	2.38

Schedule of options outstanding and exercisable

	Options Outstanding				Options Exercisable
Exercise Prices	Number		Price	Life*	Number		Price*
$2.70	22,264	$	2.70	0.75	22,264	$	2.70
$2.90	53,128	$	2.90	4.11	53,128	$	2.90
$4.26	171,197	$	4.26	5.73	171,197	$	4.26
$2.79	772,194	$	2.79	7.23	553,122	$	2.79
$1.79	198,750	$	1.79	7.87	68,437	$	1.79
$1.21	389,386	$	1.21	8.95	292,039	$	1.21
$0.40	50,000	$	0.40	9.69	–	$	0.40
Total - September 30, 2023	1,656,919	$	2.38		1,160,187	$	2.59

*	Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

Schedule of restricted stock units outstanding


	Restricted Stock Units			Weighted Average Grant Date Fair Value
Outstanding - December 31, 2022		563,859		$	2.14
Granted		37,500			1.24
Forfeited/canceled		(118,350	)		1.83
Vested/issued		(195,759	)		1.83
Outstanding - September 30, 2023		287,250		$	2.37

Schedule of warrant outstanding

Schedule of warrant outstanding
	Warrants		Weighted Average Exercise Price
Outstanding - December 31, 2022		4,472,099	$	4.62
Granted		950,000		0.61
Forfeited/canceled		–		–
Exercised		–		–
Outstanding - September 30, 2023		5,422,099	$	3.84

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Accounting Policies [Abstract]
Cash	$ 2,199,678		$ 2,199,678		$ 1,661,434
Cash equivalents, at carrying value	0		0		0
Cash, uninsured amount	1,900,000		1,900,000		$ 1,400,000
Software development costs incurred	213,705	$ 394,893	743,208	$ 1,673,517
Amortization of software development costs	$ 458,973	$ 262,703	$ 1,331,823	$ 693,441

Property & Equipment and Software Development Costs (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (85,118)	$ (66,121)
Total property and equipment, net	22,084	41,080
Accumulated amortization	(3,823,647)	(2,491,824)
Total software development costs, net	3,545,610	4,134,225
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computers and equipment, gross	99,939	99,939
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Furniture, gross	7,263	7,262
Software Development [Member]
Property, Plant and Equipment [Line Items]
Software, gross	$ 7,369,257	$ 6,626,049

Property & Equipment and Software Development Costs (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 6,193	$ 12,136	$ 18,997	$ 28,529
Equipment and amortization expense	$ 458,973	$ 262,703	$ 1,331,823	$ 693,441

Accounts payable and accrued liabilities (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued liabilities	$ 269,159	$ 289,955
Credit cards payable	14,517	6,072
Accrued interest	303,965	28,111
Total accounts payable and accrued liabilities	$ 587,641	$ 324,138

Notes Payable to Related Party, net of debt issuance costs (Details Narrative) - Prior Note [Member] - USD ($)		1 Months Ended		3 Months Ended	9 Months Ended
	Nov. 30, 2022	May 31, 2023	Apr. 30, 2023	Sep. 30, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Debt face amount	$ 2,200,000
Original issue discount	$ 200,000
Warrants issued, shares	300,000
Warrants issued, value	$ 361,878
New Note [Member]
Debt Instrument [Line Items]
Debt face amount			$ 825,000
Original issue discount			$ 75,000
Warrants issued, shares			325,000
Debt face amount				$ 825,000	$ 825,000
Interest expense, debt				$ 401,441	$ 401,441
Additional Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares			325,000
Warrants issued, value			$ 252,940
Additional Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares		300,000
Warrants issued, value		$ 94,083
Original Issued Warrants [Member]
Debt Instrument [Line Items]
Warrants cancelled, shares			300,000
New Common Stock Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares			600,000
Warrants issued, value			$ 35,981
Warrants vested		300,000	300,000
Warrants unvested			300,000

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 12,053	$ 39,935	$ 49,491	$ 83,117
Equity, Attributable to Parent	$ 2,415,012	$ 4,767,353	$ 2,415,012	$ 4,767,353	$ 4,331,777	$ 2,095,247	$ 3,850,083	$ 6,143,327	$ 7,915,053	$ 9,410,937

Share-based Issuances (Details - Option Activity) - Equity Option [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning \| shares	1,663,173
Weighted average exercise price, beginning \| $ / shares	$ 2.45
Options granted \| shares	200,200
Weighted average exercise price, granted \| $ / shares	$ 0.94
Options forfeited/cancelled \| shares	(206,454)
Weighted average exercise price, forfeited/canceled \| $ / shares	$ 1.51
Options exercised \| shares	0
Weighted average exercise price, exercised \| $ / shares	$ 0
Outstanding, ending \| shares	1,656,919
Weighted average exercise price, ending \| $ / shares	$ 2.38

Share-based Issuances (Details - Options by Exercise Price) - Equity Option [Member] - $ / shares

9 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

1,656,919

1,663,173

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 2.38

$ 2.45

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

1,160,187

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 2.59

Exercise Price 1 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

22,264

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 2.70

Weighted average contractual term

^[1]

9 months

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

22,264

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 2.70

Exercise Price 2 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

53,128

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 2.90

Weighted average contractual term

^[1]

4 years 1 month 9 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

53,128

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 2.90

Exercise Price 3 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

171,197

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 4.26

Weighted average contractual term

^[1]

5 years 8 months 23 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

171,197

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 4.26

Exercise Price 4 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

772,194

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 2.79

Weighted average contractual term

^[1]

7 years 2 months 23 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

553,122

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 2.79

Exercise Price 5 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

198,750

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 1.79

Weighted average contractual term

^[1]

7 years 10 months 13 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

68,437

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 1.79

Exercise Price 6 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

389,386

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 1.21

Weighted average contractual term

^[1]

8 years 11 months 12 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

292,039

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 1.21

Exercise Price 7 [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

50,000

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$ 0.40

Weighted average contractual term

^[1]

9 years 8 months 8 days

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

^[1]

$ 0.40

[1]	Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

Share-based Issuances (Details - Restricted Stock Units Activity) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning \| shares	563,859
Weighted average exercise price, beginning \| $ / shares	$ 2.14
Restricted stock units granted \| shares	37,500
Weighted average exercise price, granted \| $ / shares	$ 1.24
Restricted stock units forfeited/cancelled \| shares	(118,350)
Weighted average exercise price, forfeited/cancelled \| $ / shares	$ 1.83
Restricted Stock Units vested issued \| shares	(195,759)
Weighted average exercise price, vested issued \| $ / shares	$ 1.83
Outstanding, ending \| shares	287,250
Weighted average exercise price, ending \| $ / shares	$ 2.37

Share-based Issuances (Details - Warrant Activity) - Warrant [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning \| shares	4,472,099
Weighted average exercise price, beginning \| $ / shares	$ 4.62
Warrants granted \| shares	950,000
Weighted average exercise price, granted \| $ / shares	$ 0.61
Warrants Forfeited/cancelled \| shares	0
Weighted average exercise price, granted \| $ / shares	$ 0
Warrants Exercised \| shares	0
Weighted average exercise price, granted \| $ / shares	$ 0
Warrants outstanding, ending \| shares	5,422,099
Weighted average exercise price, ending \| $ / shares	$ 3.84

Share-based Issuances (Details Narrative) - USD ($)	9 Months Ended
Share-based Issuances (Details Narrative) - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation	$ 799,677	$ 698,486
Share-based compensation expense	$ 1,447,278
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units granted	200,200
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units granted	37,500
Fair value of vested shares over the service	$ 45,981
Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding	5,422,099		4,472,099
Warrants remaining contractual life	2 years 8 months 8 days

Net Loss Per Share (Details Narrative) - shares	9 Months Ended
Net Loss Per Share (Details Narrative) - shares	Sep. 30, 2023	Sep. 30, 2022
Net loss per share attributable to common stockholders
Dilutive weighted average shares	7,079,016	6,271,219

Equity Financings (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	9 Months Ended
Equity Financings (Details Narrative) - USD ($)	Jun. 30, 2023	Apr. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of stock				$ 4,016,521	$ 0
S-3 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued new, shares	4,735,000
Proceeds from sale of stock	$ 2,700,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued new, shares			7,096,514
White Lion Purchase Agreement [Member] \| Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued, shares	2,361,514	2,361,514
Number of shares issued value	$ 1,300,000	$ 1,300,000
Number of shares exceed				2,501,700